Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Two gene areas linked to male pattern baldness found, more research needed.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The compound 4c showed strong potential as an anticancer agent.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The ACE1 gene variant doesn't affect long-COVID symptoms.

The updated criteria improve the accuracy of diagnosing lupus.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

QR678 Neo is more effective than PRP for hair growth and quality.

Recent selection on immune response genes was identified across seven ethnicities.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

The patient's hair improved after treatment, but the genetic link is unclear.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

A multidisciplinary approach is crucial for managing Silver-Russell syndrome effectively.

The Thr1022Ala variant in the hairless gene is not a disease-causing mutation.